GILEAD SCIENCES, INC. is 6.8x more valuable than BioNTech SE by market capitalization ($155.93 B vs $22.90 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BNTX | GILD |
|---|---|---|
| Market cap | $22.90 B | $155.93 B |
| US-listed rank | #572 | #98 |
| Revenue (latest FY) | - | $29.44B |
| Net income (latest FY) | - | $8.51B |
| Net margin | - | 28.9% |
| P/E (trailing FY) | - | 18.3 |
| SEC filings | 548 | 981 |
GILEAD SCIENCES, INC. is 6.8x more valuable than BioNTech SE by market capitalization ($155.93 B vs $22.90 B).
Full pages: BioNTech SE and GILEAD SCIENCES, INC., or browse the full rankings.